Levozin Capsule (Levodropropizine)

Adult dose

Adults: Administer levodropropizine 60mg orally per dose 3 times daily, at intervals of at least 6 hours. Adjust the dose as appropriate according to symptoms.

This medicine should not be used by anyone who is allergic to this medication or any of its ingredients. Patients with increased bronchial mucus secretion should also avoid taking this medication. Patients with impaired mucociliary function, such as those with Kartagener syndrome or ciliary dyskinesia, should avoid this drug. Women who are pregnant or may become pregnant, as well as breastfeeding women, should refrain from taking this medication. Patients with severe liver dysfunction should not use this drug. Additionally, this medication contains lactose and should not be administered to patients with lactose intolerance or related genetic issues. Patients with severe heart failure or significantly reduced kidney function should use this medication with caution. Elderly patients should also exercise caution when taking this medication. Children under 2 years of age should be particularly careful when using this drug. This medication contains a colorant known as Yellow No. 5, and those who are allergic to or have hypersensitivity to this ingredient should use it with caution. Taking this medication can occasionally lead to gastrointestinal symptoms such as nausea, dyspepsia, diarrhea, and vomiting. Central nervous system symptoms such as fatigue, headache, and dizziness may also occur. Symptoms of rapid heartbeat have been reported, and skin allergic reactions may occur rarely. Very rarely, there is a possibility of severe immune reactions such as anaphylaxis. This medication may rarely cause a state of altered consciousness (confusion), so caution is advised when driving or operating machinery. It is especially recommended to avoid taking it with alcohol, as symptoms may worsen. If used in combination with sedatives, the effect may be enhanced, so sensitive individuals should be cautious. Pregnant or breastfeeding women should not take this medication. This medication should be stored in a safe place out of the reach of children. It is advisable to keep it in its original container, as transferring it to another container may lead to accidents or degradation of quality.

• Nausea
• carbonic acid symptoms
• dyspepsia
• diarrhea
• vomiting
• fatigue
• functional impairment
• hyporexia
• coma
• headache

This medication should be stored in a tightly closed container to prevent air or moisture from entering. Additionally, it should be stored at room temperature, avoiding extremely hot or cold places, ideally between 1 degree and 30 degrees Celsius.

Appearance

Hard capsule with upper light brown and lower pale yellow, filled with white powder

Package unit

For domestic use: 30 capsules/bottle, 300 capsules/bottle For export: 30 capsules (10 capsules/PTP X 3), 100 capsules (10 capsules/PTP X 10)